SETBP1 and Schinzel-Giedion syndrome: Furthermore, our results highlight that, despite the identification of overlapping SETBP1 mutations in SGS and myeloid malignancies, the mutation spectrum is significantly different in both conditions with functionally weaker mutations appearing predominantly as germline mutations in SGS.